Sakai N - Search Results

1

The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese.

Yokoyama H, Wada T, Hara A, Yamahana J, Nakaya I, Kobayashi M, Kitagawa K, Kokubo S, Iwata Y, Yoshimoto K, Shimizu K, Sakai N, Furuichi K; Kanazawa Study Group for Renal Diseases and Hypertension. Yokoyama H, et al. Among authors: sakai n. Kidney Int. 2004 Dec;66(6):2382-8. doi: 10.1111/j.1523-1755.2004.66027.x. Kidney Int. 2004. PMID: 15569330 Free article.

2

A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats.

Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Kobayashi KI, Mukaida N, Matsushima K, Yokoyama H. Wada T, et al. Among authors: sakai n. J Am Soc Nephrol. 2000 Aug;11(8):1534-1541. doi: 10.1681/ASN.V1181534. J Am Soc Nephrol. 2000. PMID: 10906168

3

Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice.

Furuichi K, Wada T, Iwata Y, Sakai N, Yoshimoto K, Kobayashi Ki K, Mukaida N, Matsushima K, Yokoyama H. Furuichi K, et al. Among authors: sakai n. Nephrol Dial Transplant. 2002 Mar;17(3):399-407. doi: 10.1093/ndt/17.3.399. Nephrol Dial Transplant. 2002. PMID: 11865084

4

The beneficial effects of lymphocytapheresis for treatment of nephrotic syndrome.

Yokoyama H, Shimizu M, Wada T, Yoshimoto K, Iwata Y, Shimizu K, Sakai N, Furuichi K, Hisada Y, Takakuwa H, Kobayashi K. Yokoyama H, et al. Among authors: sakai n. Ther Apher. 2002 Apr;6(2):167-73. doi: 10.1046/j.1526-0968.2002.00351.x. Ther Apher. 2002. PMID: 11982960

5

p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis.

Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Takeda S, Kida H, Kobayashi K, Mukaida N, Matsushima K, Yokoyama H. Sakai N, et al. Nephrol Dial Transplant. 2002 Jun;17(6):998-1004. doi: 10.1093/ndt/17.6.998. Nephrol Dial Transplant. 2002. PMID: 12032188

6

p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice.

Iwata Y, Wada T, Furuichi K, Sakai N, Matsushima K, Yokoyama H, Kobayashi K. Iwata Y, et al. Among authors: sakai n. J Am Soc Nephrol. 2003 Jan;14(1):57-67. doi: 10.1097/01.asn.0000037402.83851.5f. J Am Soc Nephrol. 2003. PMID: 12506138

7

Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allografts.

Azuma H, Wada T, Gotoh R, Furuichi K, Sakai N, Yazawa K, Yokoyama H, Katsuoka Y, Takahara S. Azuma H, et al. Among authors: sakai n. Transplantation. 2003 Oct 15;76(7):1029-36. doi: 10.1097/01.TP.0000090392.56694.06. Transplantation. 2003. PMID: 14557748

8

Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy.

Yoshimoto K, Yokoyama H, Wada T, Furuichi K, Sakai N, Iwata Y, Goshima S, Kida H. Yoshimoto K, et al. Among authors: sakai n. Kidney Int. 2004 Jan;65(1):148-53. doi: 10.1111/j.1523-1755.2004.00403.x. Kidney Int. 2004. PMID: 14675045 Free article.

9

Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis.

Wada T, Furuichi K, Sakai N, Iwata Y, Kitagawa K, Ishida Y, Kondo T, Hashimoto H, Ishiwata Y, Mukaida N, Tomosugi N, Matsushima K, Egashira K, Yokoyama H. Wada T, et al. Among authors: sakai n. J Am Soc Nephrol. 2004 Apr;15(4):940-8. doi: 10.1097/01.asn.0000120371.09769.80. J Am Soc Nephrol. 2004. PMID: 15034096

10

CD68 and MCP-1/CCR2 expression of initial biopsies reflect the outcomes of membranous nephropathy.

Yoshimoto K, Wada T, Furuichi K, Sakai N, Iwata Y, Yokoyama H. Yoshimoto K, et al. Among authors: sakai n. Nephron Clin Pract. 2004;98(1):c25-34. doi: 10.1159/000079924. Nephron Clin Pract. 2004. PMID: 15361701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,585 results

Search Page